INVO Bioscience Announces Uplisting to OTCQB Market
INVO Bioscience Announces Uplisting to OTCQB Market |
[29-June-2018] |
MEDFORD, Mass., June 29, 2018 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company granted FDA clearance for the first Intravaginal Culture System, INVOcellâ„¢, today announced today that its stock has commenced trading on the OTCQB Market ("OTCQB") after successfully uplisting from the OTC Pink Market.
As a verified market with efficient access to U.S. investors, the OTCQB helps companies build shareholder value with a goal of enhancing liquidity and achieving fair valuation. Multiple reporting standards also give OTCQB companies the flexibility to control reporting costs and complexity, while still providing investors with a premium market for their securities. The OTCQB is recognized by the SEC as an established public market. Their platform enables companies to provide current public information that investors need to analyze, value and trade a security. Greater visibility is also found through a large network of data distributors and media partners which ensures that trade data, news and disclosures are available to broker-dealers, market data providers, and investors. The OTCQB platform also offers better trading since investors get an exchange-comparable experience with convenient trading through their preferred broker or financial advisor who normally require a minimum QB status, transparent pricing with real-time quotes, and trusted transparency. Katie Karloff, CEO of INVO Bioscience commented, "The last year has seen a number of important milestones for INVO Bioscience as we further our mission to increase access to care and expand fertility treatment across the globe through our proprietary INVOcell device and procedure. Today's announcement of our uplisting to the OTCQB is another important step for us which helps to expands the audience of investors that can invest in the Company. We are dedicated to taking the necessary steps to drive value for our shareholders." About INVO Bioscience Safe Harbor Statement Contact:
View original content with multimedia:http://www.prnewswire.com/news-releases/invo-bioscience-announces-uplisting-to-otcqb-market-300674645.html SOURCE INVO Bioscience, Inc. | ||
Company Codes: OTC-PINK:IVOB, OTC-QB:IVOB |
© 2018 PR Newswire. All Rights Reserved.
#content-news .main-news{color:#737373;font-size:14px;line-height:inherit;text-align:inherit}